rorβ

Melatonin (Melatonine) 属于天然激素，由松果体分泌，可激活褪黑激素受体。Melatonin 是一种调节生物钟的激素，还具有抗氧化和抗炎活性。

A-9758 is a RORγ ligand and a selective RORγt inverse agonist (IC50: 5 nM) and exhibits robust potency against IL-17A release. It is effective in suppressing both Th17 differentiation and Th17 effector function. A-9758 significantly attenuates IL-23 drive

RORγ inverse agonist 1具有抗炎活性，可用来治疗风湿和银屑病。

ROR agonist-1 is a potent and orally bioavailable the retinoic acid receptor-related orphan receptor C2 (RORC2) inverse agonist(inhibition of IL-17A production from human primary TH 17 cells with a pIC50 of 7.5).

RORγt agonist 1 is a potent, orally bioavailable agonist of RORγt(EC50 of 20.8 nM).

RORγt Inverse agonist 3 is a potent, selective and orally active inverse agonist of RORγ(EC50s of 0.22 μM and 0.15 μM for hRORγ and RORγt (human IL-17 cells), respectively).

RORγt Inverse agonist 6 是 RORγt inverse 的激动剂。 RORγt Inverse agonist 6 可用于研究 Th17 驱动的自身免疫性疾病。

RORγt Inverse agonist 8 is a potent, selective, orally bioavailable RORγt inverse agonist(human RORγt-LBD with an IC50 of 19 nM).

RORγt Inverse agonist 2 is a selective, orally active inverse agonist of RORγt(EC50 of 119 nM).

RORγt inverse agonist 32 (compound b14) 表现出良好的口服活性，并可用于炎症相关的研究领域。

RORγt inverse agonist 34 (compound 5a) 是一种RORγt反向激动剂，其对RORγt-LBD的IC50为0.094 μM。该化合物应用于银屑病研究。

RORγ-IN-2 (Compound 22) 是一种有效的 RORγ 抑制剂，其对 hRORγ 的 Ki 值为 16.6 nM。RORγ-IN-2 可应用于研究 IL-17 依赖的自身免疫性疾病。

RORγt inverse agonist 33 (compound (R)-D4) 是一种具备口服生物利用度的RORγt反向激动剂，IC50为21 nM，在类风湿关节炎的研究中具有重要作用。

RORγt inhibitor 4 (Compound 9a) 是一种口服活性且能够穿透中枢神经系统的RORγt抑制剂，用于改善实验性自身免疫性脑脊髓炎。

PROTACROR1degrader-1 (Compound 11d) 是一种针对伪激酶ROR1的PROTAC降解剂，在非小细胞肺癌（NSCLC）细胞中显示出有效的ROR1降解作用，其DC50为40-80 nM。该化合物可引起聚ADP核糖聚合酶(PARP)的裂解并诱导NCI-H23细胞凋亡(apoptosis)。(Pink: ligand for target protein ROR1 ligand-1; Black: linker; Blue: ligand for VHL E3 ligase (S,R,S)-AHPC)

ROR1ligand-1 (9-1) 是 PROTAC ROR1 降解剂-1 的特定配体。通过与 VHL型或 CRBN 配体结合，开发并合成了第一个选择性和高效的 ROR1 PROTAC 分子。

ROR1-IN-2 (compound 9I) 是一种高效的ROR1特异性抑制剂。在多种癌细胞中显示出抗增殖作用，且在体内明显抑制肿瘤的发展。

RORγt inhibitor 1 is a RORγt allosteric inhibitor with an IC 50 value of 1 nM.

RORγt inverse agonist 23, an orally available novel retinoic acid receptor-related orphan receptor γt inverse agonist, is a potent and selective RORγt inverse agonist.

RORγ agonist 1 is a highly potent and orally bioavailable compound that activates the RORγ receptor. Its efficacy is demonstrated by an EC50 value of 21 nM and it exhibits antitumor activity.

RORγt Inverse agonist 10 is a highly potent and orally bioavailable compound that acts as an antagonist for the retinoic acid receptor-related orphan nuclear receptor gamma t (RORγt). With an IC50 of 51 nM, it effectively inhibits the activity of RORγt, a prominent transcription factor involved in the regulation of genes associated with the pathogenesis of psoriasis, including IL-17A, IL-22, and IL-23R.

RORγt/DHODH-IN-2 (compound 1) 是一种有效的 RORγt/DHODH 双重抑制剂，能够用于研究炎症性肠病 (IBD)。

RORγt inverse agonist 30 (Compound 1) 是一种有效的 RORγt 反向激动剂 (IC50: 46 nM)。靶向核受体 RORγt 能够有效治疗自身免疫性疾病。

RORγt inverse agonist 29 是一种有效的、选择性的、口服具有活力的 RORγt 反向激动剂，其 IC50 值为 21 nM。RORγt inverse agonist 29 能够用于皮肤炎症和银屑病等自身免疫性疾病的研究。